Tempest Therapeutics (FRA:3OS0) Accumulated Depreciation : €-1.28 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Tempest Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Tempest Therapeutics's quarterly accumulated depreciation increased from Sep. 2024 (€-1.23 Mil) to Dec. 2024 (€-1.26 Mil) and increased from Dec. 2024 (€-1.26 Mil) to Mar. 2025 (€-1.28 Mil).

Tempest Therapeutics's annual accumulated depreciation declined from Dec. 2022 (€-1.29 Mil) to Dec. 2023 (€-0.94 Mil) but then increased from Dec. 2023 (€-0.94 Mil) to Dec. 2024 (€-1.26 Mil).

Tempest Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Tempest Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tempest Therapeutics Accumulated Depreciation Chart

Tempest Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

-0.38

-0.73

-1.29

-0.94

-1.26

Tempest Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-1.02	-1.18	-1.23	-1.26	-1.28

Tempest Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Tempest Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Tempest Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tempest Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tempest Therapeutics Inc (FRA:3OS0) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

TPST:USA

Address

2000 Sierra Point Parkway, Suite 400, Brisbane, CA, USA, 94005

Website

https://www.tempesttx.com

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Tempest Therapeutics Headlines

No Headlines